Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.

Suppr

超能文献

作者信息

Brockman R W, Schabel F M, Montgomery J A

出版信息

Biochem Pharmacol. 1977 Nov 15;26(22):2193-6. doi: 10.1016/0006-2952(77)90275-1.

DOI:10.1016/0006-2952(77)90275-1

PMID:563233

Abstract

摘要

相似文献

Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.

Biochem Pharmacol. 1977 Nov 15;26(22):2193-6. doi: 10.1016/0006-2952(77)90275-1.

Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤与9-β-D-阿拉伯呋喃糖基腺嘌呤对小鼠肿瘤细胞靶酶作用的比较。

Cancer Res. 1982 Jun;42(6):2260-4.

Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.人白血病淋巴母细胞中9-β-D-阿拉伯呋喃糖基腺嘌呤与9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤在代谢及细胞毒性方面的差异

Cancer Res. 1980 May;40(5):1405-10.

Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤对小鼠白血病L1210的代谢及化疗活性及其经脱氧胞苷激酶磷酸化的证据

Cancer Res. 1980 Oct;40(10):3610-5.

Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells.

Cancer Res. 1983 Jan;43(1):104-9.

Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.9-β-D-阿拉伯呋喃糖基腺嘌呤掺入L1210 DNA与细胞毒性之间的关系。

Cancer Res. 1983 May;43(5):2000-4.

Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.2'-脱氧助间型霉素增强9-β-D-阿拉伯呋喃糖基腺嘌呤对小鼠白血病L1210细胞的体外细胞毒性。

Cancer Res. 1976 Apr;36(4):1486-91.

Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.

Cancer Res. 1980 Jul;40(7):2349-55.

Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.抗肿瘤和抗病毒药物9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤的代谢产物鉴定

Biochem Pharmacol. 1982 Jun 1;31(11):1975-8. doi: 10.1016/0006-2952(82)90407-5.

Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤掺入HL-60细胞的RNA和DNA中。

Biochem Pharmacol. 1986 Jan 15;35(2):247-52. doi: 10.1016/0006-2952(86)90521-6.

引用本文的文献

Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review.嘌呤和嘧啶衍生物的抗癌潜力及构效关系研究：最新综述

Mol Divers. 2025 Feb;29(1):817-848. doi: 10.1007/s11030-024-10870-4. Epub 2024 Jun 10.

Fludarabine Inhibits Infection of Zika Virus, SFTS Phlebovirus, and Enterovirus A71.氟达拉滨抑制寨卡病毒、发热伴血小板减少综合征布尼亚病毒和肠道病毒 A71 的感染。

Viruses. 2021 Apr 27;13(5):774. doi: 10.3390/v13050774.

Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?核糖核苷酸还原酶抑制剂的临床药理学与临床试验：它是一种可行的癌症治疗方法吗？

J Cancer Res Clin Oncol. 2017 Aug;143(8):1499-1529. doi: 10.1007/s00432-017-2457-8. Epub 2017 Jun 17.

Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors.基于药效团的筛选和药物再利用：以糖原合酶激酶-3抑制剂为例

Mol Divers. 2017 May;21(2):385-405. doi: 10.1007/s11030-016-9724-5. Epub 2017 Jan 21.

New insights into the synergism of nucleoside analogs with radiotherapy.核苷类似物与放射疗法协同作用的新见解。

Radiat Oncol. 2013 Sep 26;8:223. doi: 10.1186/1748-717X-8-223.

Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants.开发具有超高抗 HIV 活性和低毒性的修饰核苷，并预防耐药性 HIV 突变体的出现。

Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(3):53-65. doi: 10.2183/pjab.87.53.

Fludarabine in the treatment of chronic lymphocytic leukemia: a review.氟达拉滨治疗慢性淋巴细胞白血病：综述。

Ther Clin Risk Manag. 2009 Feb;5(1):187-207. doi: 10.2147/tcrm.s3688. Epub 2009 Mar 26.

Cellular and clinical pharmacology of fludarabine.氟达拉滨的细胞和临床药理学

Clin Pharmacokinet. 2002;41(2):93-103. doi: 10.2165/00003088-200241020-00002.

Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.氟达拉滨。其药理学及在血液系统恶性肿瘤治疗中应用的最新进展。

Drugs. 1997 Jun;53(6):1005-37. doi: 10.2165/00003495-199753060-00007.

Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.氟达拉滨。其药理特性及在恶性肿瘤治疗中的潜力综述。

Drugs. 1993 May;45(5):737-59. doi: 10.2165/00003495-199345050-00009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验